Human Genome Epidemiology Literature Finder
Records 1 - 19 (of 19 Records) |
Query Trace: Myelofibrosis and U2AF1[original query] |
---|
A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients. British journal of haematology 2015 Apr 169 (1): 71-6. Wassie Emnet, Finke Christy, Gangat Naseema, Lasho Terra L, Pardanani Animesh, Hanson Curtis A, Ketterling Rhett P, Tefferi Ayal |
Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations. Blood cancer journal 2016 6 e416. Barraco D, Elala Y C, Lasho T L, Begna K H, Gangat N, Finke C, Hanson C A, Ketterling R P, Pardanani A, Tefferi |
Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations. Blood cancer journal 2016 6 e415. Barraco D, Elala Y C, Lasho T L, Begna K H, Gangat N, Finke C, Hanson C A, Ketterling R P, Pardanani A, Tefferi |
Application of an NGS-based 28-gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera. British journal of haematology 2016 Nov 175 (3): 419-426. Delic Sabit, Rose Dominic, Kern Wolfgang, Nadarajah Niroshan, Haferlach Claudia, Haferlach Torsten, Meggendorfer Man |
Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis. Journal of hematology & oncology 2017 05 10 (1): 99. Li Bing, Gale Robert Peter, Xu Zefeng, Qin Tiejun, Song Zhen, Zhang Peihong, Bai Jie, Zhang Lei, Zhang Yue, Liu Jinqin, Huang Gang, Xiao Zhiji |
Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL mutation. European journal of haematology 2019 Aug . Mannina Daniele, Gagelmann Nico, Badbaran Anita, Ditschkowski Markus, Bogdanov Rashit, Robin Marie, Cassinat Bruno, Heuser Michael, Shahswar Rabia, Thol Felicitas, Beelen Dietrich, Kröger Nicola |
Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis. Molecular cancer therapeutics 2019 4 18 (6): 1149-1157. Janku Filip, Diamond Eli L, Goodman Aaron M, Raghavan Vaijayanthi Kandadai, Barnes Tamara G, Kato Shumei, Abdel-Wahab Omar, Durham Benjamin H, Meric-Bernstam Funda, Kurzrock Razel |
Mutational profiling in myelofibrosis: implications for management. International journal of hematology 2019 10 111 (2): 192-199. Bose Prithviraj, Verstovsek Srd |
Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2019 1 25 (6): 1142-1151. Tamari Roni, Rapaport Franck, Zhang Nan, McNamara Caroline, Kuykendall Andrew, Sallman David A, Komrokji Rami, Arruda Andrea, Najfeld Vesna, Sandy Lonette, Medina Juan, Litvin Rivka, Famulare Christopher A, Patel Minal A, Maloy Molly, Castro-Malaspina Hugo, Giralt Sergio A, Weinberg Rona S, Mascarenhas John O, Mesa Ruben, Rondelli Damiano, Dueck Amylou C, Levine Ross L, Gupta Vikas, Hoffman Ronald, Rampal Raajit |
Retrospective Analysis of the Clinical Use and Benefit of Lenalidomide and Thalidomide in Myelofibrosis. Clinical lymphoma, myeloma & leukemia 2020 8 20 (12): e956-e960. Castillo-Tokumori Franco, Talati Chetasi, Al Ali Najla, Sallman David, Yun Seongseok, Sweet Kendra, Padron Eric, Lancet Jeffrey, Komrokji Rami, Kuykendall Andrew |
Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera. British journal of haematology 2020 1 189 (2): 291-302. Tefferi Ayalew, Guglielmelli Paola, Lasho Terra L, Coltro Giacomo, Finke Christy M, Loscocco Giuseppe G, Sordi Benedetta, Szuber Natasha, Rotunno Giada, Pacilli Annalisa, Hanson Curtis A, Ketterling Rhett P, Pardanani Animesh, Gangat Naseema, Vannucchi Alessandro |
Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases. American journal of hematology 2021 (7): 781-789. Gangat Naseema, Guglielmelli Paola, Szuber Natasha, Begna Kebede H, Patnaik Mrinal M, Litzow Mark R, Al-Kali Aref, Foran James M, Palmer Jeanne M, Alkhateeb Hassan, Elliott Michelle A, Hanson Curtis A, Pardanani Animesh, Mannelli Francesco, Vannucchi Alessandro M, Tefferi Ayal |
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study. Blood advances 2021 Mar 5 (5): 1442-1451. Luque Paz Damien, Riou Jérémie, Verger Emmanuelle, Cassinat Bruno, Chauveau Aurélie, Ianotto Jean-Christophe, Dupriez Brigitte, Boyer Françoise, Renard Maxime, Mansier Olivier, Murati Anne, Rey Jérôme, Etienne Gabriel, Mansat-De Mas Véronique, Tavitian Suzanne, Nibourel Olivier, Girault Stéphane, Le Bris Yannick, Girodon François, Ranta Dana, Chomel Jean-Claude, Cony-Makhoul Pascale, Sujobert Pierre, Robles Margot, Ben Abdelali Raouf, Kosmider Olivier, Cottin Laurane, Roy Lydia, Sloma Ivan, Vacheret Fabienne, Wemeau Mathieu, Mossuz Pascal, Slama Borhane, Cussac Vincent, Denis Guillaume, Walter-Petrich Anouk, Burroni Barbara, Jézéquel Nathalie, Giraudier Stéphane, Lippert Eric, Socié Gérard, Kiladjian Jean-Jacques, Ugo Valér |
Clinical impacts of the mutational spectrum in Japanese patients with primary myelofibrosis. International journal of hematology 2021 Jan . Morishita Soji, Ochiai Tomonori, Misawa Kyohei, Osaga Satoshi, Inano Tadaaki, Fukuda Yasutaka, Edahiro Yoko, Ohsaka Akimichi, Araki Marito, Komatsu Nor |
Combination of myeloproliferative neoplasm driver gene activation with mutations of splice factor or epigenetic modifier genes increases risk of rapid blastic progression. European journal of haematology 2021 1 106 (4): 520-528. Bartels Stephan, Vogtmann Julia, Schipper Elisa, Büsche Guntram, Schlue Jerome, Lehmann Ulrich, Kreipe Ha |
JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome. Journal of cancer research and clinical oncology 2022 Oct . Kandu?a Zuzanna, Janowski Micha?, Wi?ckowska Barbara, Paczkowska Edyta, Lewandowski Krzyszt |
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity. Blood cancer journal 2023 9 13 (1): 149. Talha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, James M Foran, Aref Al-Kali, Abhishek Mangaonkar, Hemant Murthy, Hassan B Alkhateeb, David Viswanatha, Rong He, Mithun Shah, Cecilia Arana Yi, Mark R Litzow, Naseema Gangat, Ayalew Tefferi, Mrinal M Patna |
The clinical relevance of broad mutational screening of myeloproliferative neoplasms at diagnosis. Frontiers in oncology 2023 8 13 1190305. Helna Pettersson, Jenni Adamsson, Peter Johansson, Staffan Nilsson, Lars Palmqvist, Björn Andréasson, Julia A |
The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms. British journal of haematology 2023 5 . Mark Gurney, Ismahene Chekkaf, Anmol Baranwal, Rami Basmaci, Bahga Katamesh, Patricia Greipp, James M Foran, Talha Badar, Abhishek A Mangaonkar, Kebede H Begna, Naseema Gangat, Mrinal M Patnaik, Mark R Litzow, Mithun V Shah, David S Viswanatha, Rong He, Hassan B Alkhateeb, Aref Al-Ka |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: